Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia
- 26 May 2023
- journal article
- research article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 37 (4) , 787-799
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology ResourceJournal of Clinical Oncology, 2013
- The role of 18F‐FDG PET/CT imaging in Waldenstrom macroglobulinemiaAmerican Journal of Hematology, 2011
- The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformationBlood, 2011
- Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapyAnnals of Oncology, 2009
- Increased Incidence of Transformation and Myelodysplasia/Acute Leukemia in Patients With Waldenström Macroglobulinemia Treated With Nucleoside AnalogsJournal of Clinical Oncology, 2009
- Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell TransplantationJournal of Clinical Oncology, 2006
- Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayBlood, 2004
- Diffuse Large B-Cell Lymphoma Occurring in Patients With Lymphoplasmacytic Lymphoma/Waldenström MacroglobulinemiaAmerican Journal of Clinical Pathology, 2003
- Immunoblastic lymphoma and associated non‐lymphoid malignancies following two cases of Waldenström's macroglobulinemia. A review of the literatureEuropean Journal of Haematology, 1993
- RETICULUM CELL SARCOMA IN WALDENSTRÖM'S MACROGLOBULINEMIA AFTER CHLORAMBUCIL TREATMENTActa Medica Scandinavica, 1970